Chan T Y, Critchley J A, Ho C S, Chan A Y
Department of Clinical Pharmacology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.
Postgrad Med J. 1995 Nov;71(841):678-80. doi: 10.1136/pgmj.71.841.678.
Previously, prior approval from the on-call chemical pathologist was required in our hospital for plasma paracetamol measurements. However, since May 1992, there have been no restrictions on ordering this assay. We have assessed the consequences of this policy change by comparing the number and appropriateness of requests for plasma paracetamol measurements in Chinese patients admitted to our hospital with acute poisoning over two six-month periods (July-December) in 1991 and 1993. Requests were considered appropriate if paracetamol ingestion was suspected or unknown drugs were ingested. The number of patients having plasma paracetamol concentrations assayed increased from 51 in 1991 to 141 in 1993 (176%). The corresponding increase in the number of Chinese patients admitted to two of our eight general wards with poisoning was estimated to be 93%. The proportion of 'appropriate' plasma paracetamol measurements dropped from 55% in 1991 to 21% in 1993. Eight patients had plasma paracetamol concentrations above the recommended treatment line; they were all from the group in whom the requests were appropriate. Three of the 135 patients in the group with 'inappropriate' requests were found to have slightly elevated but far from toxic plasma paracetamol concentrations. Unrestricted availability of plasma paracetamol measurements resulted in an increase in the number of inappropriate requests.
此前,在我们医院,进行血浆对乙酰氨基酚检测需要获得随叫随到的化学病理学家的事先批准。然而,自1992年5月以来,订购该检测项目不再有任何限制。我们通过比较1991年和1993年两个为期六个月的时间段(7月至12月)内入住我院的急性中毒中国患者血浆对乙酰氨基酚检测请求的数量和合理性,评估了这一政策变化的后果。如果怀疑摄入了对乙酰氨基酚或摄入了不明药物,则认为检测请求是合理的。进行血浆对乙酰氨基酚浓度检测的患者数量从1991年的51例增加到1993年的141例(增长了176%)。据估计,我院八个普通病房中两个病房收治的中毒中国患者数量相应增加了93%。“合理的”血浆对乙酰氨基酚检测比例从1991年的55%降至1993年的21%。有8名患者的血浆对乙酰氨基酚浓度高于推荐的治疗线;他们都来自检测请求合理的组。在“不合理”请求组的135名患者中,有3名患者的血浆对乙酰氨基酚浓度略有升高,但远未达到中毒水平。血浆对乙酰氨基酚检测不受限制导致了不合理请求数量的增加。